Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
823
datasets available to search
ShareScore release 0.9.0
Dataset results
823 results for “kRas”
A Phase 1/2, Study Evaluating the Safety, Tolerability, PK, and Efficacy of Sotorasib (AMG 510) in Subjects With Solid Tumors With a Specific KRAS Mutation (CodeBreaK 100)
ClinicalTrials.gov study NCT03600883. IPD Sharing: YES. Countries: 16. Publications: 12.
Avastin and Chemotherapy Followed by a KRAS Stratified Randomization to Maintenance Treatment for First Line Treatment of Metastatic Colorectal Cancer.
ClinicalTrials.gov study NCT01229813. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Dacomitinib Plus PD-0325901 in Advanced KRAS Mutant NSCLC
ClinicalTrials.gov study NCT02039336. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Pooled Mutant KRAS-Targeted Long Peptide Vaccine Combined With Nivolumab and Ipilimumab for Patients With Resected Mismatch Repair Protein (MMR-p) Colorectal and Pancreatic Cancer
ClinicalTrials.gov study NCT04117087. IPD Sharing: NO. Countries: 1. Publications: 0.
Panitumumab After Resection of Liver Metastases From Colorectal Cancer in KRAS Wild-type Patients
ClinicalTrials.gov study NCT01384994. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-6036 Alone or in Combination in Participants With Advanced or Metastatic Solid Tumors With a KRAS G12C Mutation
ClinicalTrials.gov study NCT04449874. IPD Sharing: NO. Countries: 17. Publications: 3.
Safety and Efficacy Study of FOLFOX4+Panitumumab vs.FOLFIRI+Panitumumab in Subjects WT KRAS Colorectal Cancer and Liver-only Metastases
ClinicalTrials.gov study NCT00885885. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Garsorasib In KRAS G12C Mutant Locally Advanced and Metastatic NSCLC
ClinicalTrials.gov study NCT07294261. IPD Sharing: NO. Countries: 1. Publications: 3.
A Study of D3S-001 Monotherapy or Combination Therapy in Subjects With Advanced Solid Tumors With a KRAS p.G12C Mutation
ClinicalTrials.gov study NCT05410145. IPD Sharing: NO. Countries: 10. Publications: 1.
A Study of MK-1084 in KRAS Mutant Advanced Solid Tumors (MK-1084-001)
ClinicalTrials.gov study NCT05067283. IPD Sharing: YES. Countries: 21. Publications: 1.
JAB-21822 Activity in Adult Patients With Advanced Solid Tumors Harboring KRAS G12C Mutation
ClinicalTrials.gov study NCT05002270. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Phase 3 Study of MRTX849 With Cetuximab vs Chemotherapy in Patients With Advanced Colorectal Cancer With KRAS G12C Mutation (KRYSTAL-10)
ClinicalTrials.gov study NCT04793958. IPD Sharing: NO. Countries: 32. Publications: 0.
First-in-Human Study of JNJ-74699157 in Participants With Tumors Harboring the KRAS G12C Mutation
ClinicalTrials.gov study NCT04006301. IPD Sharing: YES. Countries: 2. Publications: 1.
Efficacy and Safety of Momelotinib Combined With Trametinib in Adults With Metastatic KRAS-mutated Non-Small Cell Lung Cancer (NSCLC) Who Have Failed Platinum-Based Chemotherapy Preceded by a Dose-fin
ClinicalTrials.gov study NCT02258607. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation
ClinicalTrials.gov study NCT06252649. IPD Sharing: YES. Countries: 33. Publications: 0.
Efficacy of Chemotherapy, Associated to Either Cetuximab or Bevacizumab, in KRAS Wild-type Metastatic Colorectal Cancer Patients With Progressive Disease After Receiving First-line Treatment With Beva
ClinicalTrials.gov study NCT01442649. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
ClinicalTrials.gov study NCT06128551. IPD Sharing: NO. Countries: 7. Publications: 1.
JAB-21822 in Combination With Cetuximab in Patients With Advanced CRC and Other Solid Tumors With KRAS G12C Mutation
ClinicalTrials.gov study NCT05194995. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Phase 1/2 Study of MRTX849 in Patients With Cancer Having a KRAS G12C Mutation KRYSTAL-1
ClinicalTrials.gov study NCT03785249. IPD Sharing: NO. Countries: 2. Publications: 7.
Efficacy Analysis of Cetuximab Plus Irinotecan in Patients With Wild-type KRAS Without Regard to Epidermal Growth Factor Receptor (EGFR) Expressions
ClinicalTrials.gov study NCT00637091. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.